Literature DB >> 793741

Polarisation fluoroimmunoassay of gentamicin.

R A Watson, J Landon, E J Shaw, D S Smith.   

Abstract

A polarisation fluoroimmunoassay has been developed for the routine determination of gentamicin levels in serum. The method employs fluorescein-labelled gentamicin which is easily, reproducibly and economically prepared and has excellent shelf-life. The assay is fast (minimum incubation time 2 min) and requires 1.25 mul of serum. There is no separation step prior to readout of results. Recovery experiments reveal no serum effects. Intra- and inter-assay coefficients of variation are of the order of 10% or less. Estimations of gentamicin levels in patient serum samples correlate closely with those obtained by bioassay (r = 0.93) and radioimmunoassy (r = 0.97).

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 793741     DOI: 10.1016/0009-8981(76)90303-x

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

Review 1.  Fluorescence polarization/anisotropy in diagnostics and imaging.

Authors:  David M Jameson; Justin A Ross
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

2.  Estimation of serum gentamicin by quenching fluoroimmunoassay.

Authors:  E J Shaw; R A Watson; J Landon; D S Smith
Journal:  J Clin Pathol       Date:  1977-06       Impact factor: 3.411

3.  Rapid, simple enzyme immunoassay for gentamicin.

Authors:  P J Wills; R Wise
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

4.  Fluorescence immunoassay based on long time correlations of number fluctuations.

Authors:  D F Nicoli; J Briggs; V B Elings
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

5.  Evaluation of an enzyme immunoassay for serum gentamicin.

Authors:  T D O'Leary; R M Ratcliff; T D Geary
Journal:  Antimicrob Agents Chemother       Date:  1980-05       Impact factor: 5.191

Review 6.  Serum level monitoring of antibacterial drugs. A review.

Authors:  M Wenk; S Vozeh; F Follath
Journal:  Clin Pharmacokinet       Date:  1984 Nov-Dec       Impact factor: 6.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.